Published in J Clin Invest on January 01, 1972
Thrombin-induced protein phosphorylation in human platelets. J Clin Invest (1975) 1.76
Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets. J Clin Invest (1982) 1.59
The human complement system in thrombin-mediated platelet function. J Exp Med (1978) 1.36
Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments. J Clin Invest (1975) 1.32
Induction of the platelet release reaction by phytohemagglutinin. J Clin Invest (1974) 1.23
Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev (2014) 1.07
The perturbation of thrombin binding to human platelets by anions. J Clin Invest (1975) 1.07
Enhancement of platelet function by superoxide anion. J Clin Invest (1977) 1.04
The effects of thrombin on phytohemagglutinin receptor sites in human platelets. J Cell Biol (1974) 1.02
Retention of the glycoprotein IIb-IIIa complex in the isolated platelet cytoskeleton. Effects of separable assembly of platelet pseudopodal and contractile cytoskeletons. J Clin Invest (1984) 0.91
Thrombin-induced platelet secretion. Further evidence for a specific pathway. J Clin Invest (1979) 0.86
Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets. J Clin Invest (1972) 0.79
The effect of an inhibitor of the thrombin-fibrinogen reaction on thrombin-induced blood-platelet aggregation. Biochem J (1972) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem (1969) 142.11
Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med (1955) 13.98
A simple, sensitive method for the assay of adenyl cyclase. J Pharmacol Exp Ther (1968) 8.05
Observations on molecular weight determinations on polyacrylamide gel. J Biol Chem (1969) 7.60
Simple method for quantitive densitometry of polyacrylamide gels using fast green. Anal Biochem (1970) 6.03
Separation and characterization of the subunits of ribonucleic acid polymerase. J Biol Chem (1969) 4.98
A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci U S A (1971) 2.97
A deoxyribonuclease from calf spleen. II. Mode of action. J Biol Chem (1957) 2.56
Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1. Biochem Biophys Res Commun (1969) 1.89
Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J (1967) 1.85
Adenyl cyclase activity in human platelets. Biochem Biophys Res Commun (1969) 1.84
Studies on plasma membranes. 3. Mg2+-ATPase,(Na+-K+-Mg2+)-ATPase and 5'-nucleotidase activity of plasma membranes isolated from rat liver. Biochim Biophys Acta (1966) 1.76
Activation of skeletal adenyl cyclase by parathyroid hormone in vitro. Endocrinology (1969) 1.65
Lipid metabolism in human platelets. II. De novo phospholipid synthesis and the effect of thrombin on the pattern of synthesis. J Clin Invest (1969) 1.62
Effects of prostaglandins, epinephrine and NaF on human leukocyte, platelet and liver adenyl cyclase. Blood (1970) 1.57
Cyclic 3',5'-adenosine monophosphate in human blood platelets. Nature (1969) 1.40
Thrombosthenin M. Purification and interaction with thrombin. Eur J Biochem (1969) 1.34
Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function. J Clin Invest (1971) 1.26
Adenyl cyclase in human platelets: activity and responsiveness. Biochem Biophys Res Commun (1969) 1.26
Inhibition of platelet energy production and release reaction by PGE1, theophylline and cAMP. Biochem Biophys Res Commun (1970) 1.19
Lipid metabolism in human platelets. I. Evidence for a complete fatty acid synthesizing system. J Clin Invest (1969) 1.12
Beta-adrenergic receptors in human platelets. J Atheroscler Res (1969) 1.07
An improved transverse destaining apparatus for acrylamide gels. Anal Biochem (1970) 1.04
Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci U S A (1975) 4.92
The metabolism of phosphoinositide-derived messenger molecules. Science (1986) 3.58
Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc Natl Acad Sci U S A (1979) 3.48
The binding of thrombin to the surface of human platelets. J Biol Chem (1974) 3.41
Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone. J Clin Invest (1969) 3.41
The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest (1975) 3.40
A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci U S A (1971) 2.97
Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin. Science (1968) 2.90
Radioimmunoassay for cyclic nucleotides. II. Adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in mammalian tissues and body fluids. J Biol Chem (1972) 2.84
Parathyroid function and the renal excretion of 3'5'-adenylic acid. Proc Natl Acad Sci U S A (1967) 2.81
SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase. Proc Natl Acad Sci U S A (1998) 2.73
The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc Natl Acad Sci U S A (1996) 2.68
Fraud in medical research. Presidential address delivered before the 74th annual meeting of the American Society for Clinical Investigation, Washington, DC, 8 May 1982. J Clin Invest (1982) 2.62
Properties of the factor Xa binding site on human platelets. J Biol Chem (1978) 2.59
Isolation of a phosphomonoesterase from human platelets that specifically hydrolyzes the 5-phosphate of inositol 1,4,5-trisphosphate. J Biol Chem (1985) 2.55
Isolation and properties of a thrombin-sensitive protein of human platelets. J Biol Chem (1972) 2.54
Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest (1978) 2.40
Formation of phosphatidylinositol 3-phosphate by isomerization from phosphatidylinositol 4-phosphate. Proc Natl Acad Sci U S A (1991) 2.35
Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin. Biochem Biophys Res Commun (1977) 2.30
Protein kinase C phosphorylates human platelet inositol trisphosphate 5'-phosphomonoesterase, increasing the phosphatase activity. Cell (1986) 2.15
Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet (1972) 2.13
Identification, cloning, and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to cytoskeletal protein 4.1. Proc Natl Acad Sci U S A (1991) 2.04
Interaction of coagulation factor Xa with human platelets. Proc Natl Acad Sci U S A (1977) 2.03
Isolation and characterization of the inositol cyclic phosphate products of polyphosphoinositide cleavage by phospholipase C. Physiological effects in permeabilized platelets and Limulus photoreceptor cells. J Biol Chem (1985) 1.98
Structure and function of thrombomodulin: a natural anticoagulant. Blood (1990) 1.96
Isolation and quantitation of the platelet membrane glycoprotein deficient in thrombasthenia using a monoclonal hybridoma antibody. J Clin Invest (1980) 1.95
Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol (1985) 1.92
Isolation of human platelets and platelet surface membranes. Methods Enzymol (1974) 1.91
Acetyl coenzyme A carboxylase. The roles of synthesis and degradation in regulation of enzyme levels in rat liver. J Biol Chem (1969) 1.91
The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X. Anal Biochem (1980) 1.89
The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase. Proc Natl Acad Sci U S A (1995) 1.87
Thrombin-induced protein phosphorylation in human platelets. J Clin Invest (1975) 1.76
Structure and function of the acyl carrier protein. Fed Proc (1967) 1.76
Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1. J Immunol (1985) 1.76
Phosphoinositide interconversion in thrombin-stimulated human platelets. J Biol Chem (1985) 1.74
Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene. Biochemistry (1987) 1.72
Purification and characterization of human coagulation factor V. J Biol Chem (1981) 1.67
Phosphatidylinositol 3-phosphate is present in normal and transformed fibroblasts and is resistant to hydrolysis by bovine brain phospholipase C II. J Biol Chem (1989) 1.67
Activation of skeletal adenyl cyclase by parathyroid hormone in vitro. Endocrinology (1969) 1.65
Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions. J Clin Invest (1977) 1.63
Lipid metabolism in human platelets. II. De novo phospholipid synthesis and the effect of thrombin on the pattern of synthesis. J Clin Invest (1969) 1.62
Purification and properties of human coagulation factor VII. J Biol Chem (1980) 1.61
The cDNA cloning and characterization of inositol polyphosphate 4-phosphatase type II. Evidence for conserved alternative splicing in the 4-phosphatase family. J Biol Chem (1997) 1.60
Hydrolysis of polyphosphoinositides by purified sheep seminal vesicle phospholipase C enzymes. J Biol Chem (1984) 1.60
Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate. J Biol Chem (1983) 1.59
The binding of phytohemagglutinins to human platelet plasma membranes. J Biol Chem (1972) 1.59
The isolation and characterization of a cDNA encoding phospholipid-specific inositol polyphosphate 5-phosphatase. J Biol Chem (2000) 1.58
The effect of parathyroid hormone on the concentration of adenosine 3',5'-monophosphate in skeletal tissue in vitro. J Biol Chem (1970) 1.58
Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2. Curr Biol (1996) 1.57
Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate. J Biol Chem (1998) 1.56
The measurement of thrombin in clotting blood by radioimmunoassay. J Clin Invest (1976) 1.56
Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts. Cell (1979) 1.55
The isolation and characterization of cDNA encoding human and rat brain inositol polyphosphate 4-phosphatase. J Biol Chem (1995) 1.54
Production of phosphoinositide-derived messengers. Cell (1984) 1.54
Identification and properties of two distinct phosphatidylinositol-specific phospholipase C enzymes from sheep seminal vesicular glands. J Biol Chem (1982) 1.54
Pathway for inositol 1,3,4-trisphosphate and 1,4-bisphosphate metabolism. Proc Natl Acad Sci U S A (1987) 1.53
Isolation and characterization of thrombomodulin from human placenta. J Biol Chem (1984) 1.50
Secretion and metabolic efficacy of parthyroid hormone in patients with severe hypomagnesemia. J Clin Endocrinol Metab (1974) 1.49
Inositol cyclic phosphates are produced by cleavage of phosphatidylphosphoinositols (polyphosphoinositides) with purified sheep seminal vesicle phospholipase C enzymes. Proc Natl Acad Sci U S A (1985) 1.49
Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure. Proc Natl Acad Sci U S A (1995) 1.47
Arachidonate metabolism in vascular disorders. J Clin Invest (1983) 1.43
Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets. J Clin Invest (1978) 1.42
Parathyroid hormone-sensitive adenyl cyclase in isolated renal tubules. Endocrinology (1970) 1.41
The metabolism of tris- and tetraphosphates of inositol by 5-phosphomonoesterase and 3-kinase enzymes. J Biol Chem (1987) 1.41
Thrombin-induced hydrolysis of phosphatidylinositol in human platelets. J Biol Chem (1980) 1.39
Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med (1979) 1.39
Inositol polyphosphate 1-phosphatase from calf brain. Purification and inhibition by Li+, Ca2+, and Mn2+. J Biol Chem (1987) 1.38
Properties of type II inositol polyphosphate 5-phosphatase. J Biol Chem (1995) 1.38
Tyrosine aminotransferase: enzyme induction independent of adenosine 3', 5'-monophosphate. Science (1968) 1.37
Discovery of an arachidonoyl coenzyme A synthetase in human platelets. J Biol Chem (1982) 1.36
Acyl carrier protein. VII. The primary structure of the substrate-binding site. J Biol Chem (1965) 1.35
The activation loop of phosphatidylinositol phosphate kinases determines signaling specificity. Mol Cell (2000) 1.34
The structure and function of mouse thrombomodulin. Phorbol myristate acetate stimulates degradation and synthesis of thrombomodulin without affecting mRNA levels in hemangioma cells. J Biol Chem (1988) 1.34
Inositol hexakisphosphate binds to clathrin assembly protein 3 (AP-3/AP180) and inhibits clathrin cage assembly in vitro. J Biol Chem (1995) 1.32
Phosphatidylinositol-4-phosphate 5-kinase isozymes catalyze the synthesis of 3-phosphate-containing phosphatidylinositol signaling molecules. J Biol Chem (1997) 1.32
The metabolism of inositol 1,3,4-trisphosphate to inositol 1,3-bisphosphate. J Biol Chem (1987) 1.32
Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments. J Clin Invest (1975) 1.32
Isolation of inositol 1,3,4-trisphosphate 5/6-kinase, cDNA cloning and expression of the recombinant enzyme. J Biol Chem (1996) 1.30
Lack of covalent modification of prostaglandin synthetase (cyclo-oxygenase) by indomethacin. Prostaglandins (1977) 1.30
The effects of mepacrine and p-bromophenacyl bromide on arachidonic acid release in human platelets. Arch Biochem Biophys (1982) 1.29
The regulation of fatty acid biosynthesis in rat hepatomas. J Biol Chem (1968) 1.29
Factor Va-dependent binding of factor Xa to human platelets. J Biol Chem (1980) 1.28
Isolation and characterization of two 3-phosphatases that hydrolyze both phosphatidylinositol 3-phosphate and inositol 1,3-bisphosphate. J Biol Chem (1991) 1.27
Isolation and characterization of the inositol cyclic phosphate products of phosphoinositide cleavage by phospholipase C. Metabolism in cell-free extracts. J Biol Chem (1986) 1.25
Hydrolysis of phosphatidylinositol 3,4-bisphosphate by inositol polyphosphate 4-phosphatase isolated by affinity elution chromatography. J Biol Chem (1994) 1.25
Glutathione synthetase deficiency as a cause of hereditary hemolytic disease. N Engl J Med (1970) 1.23
Induction of the platelet release reaction by phytohemagglutinin. J Clin Invest (1974) 1.23
A randomized study: small cell anaplastic lung cancer treated by combination chemotherapy and adjuvant radiotherapy. Int J Radiat Oncol Biol Phys (1980) 1.21
Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder. Blood (1979) 1.20
Glutathione biosynthesis in human erythrocytes. I. Identification of the enzymes of glutathione synthesis in hemolysates. J Clin Invest (1971) 1.20
The protein tyrosine phosphatase SHP-1 regulates integrin-mediated adhesion of macrophages. Curr Biol (1998) 1.19